Health Secretary Robert F. Kennedy Jr.'s call to review a decades-old drug used for abortion received swift pushback from critics who say the effort is based on bad information and is a threat to an increasingly endangered reproductive rights landscape.
Kennedy agreed with a senator on Wednesday that a recent study from a conservative think tank, the Ethics & Public Policy Center, warrants a review of the abortion drug mifepristone.
The fight around mifepristone sits at the center of the reproductive rights landscape. Anti-abortion advocates have fought in courts and on the policy front to have the Food and Drug ...